CoChat
Sign Up
Cited by 17Abdominal vascular conditions and treatmentsPeripheral Artery Disease ManagementInfectious Aortic and Vascular Conditions

Outcomes of reoperative open or endovascular interventions to treat patients with failing open mesenteric reconstructions for mesenteric ischemia

Open access
Kanamori, Karina S., Oderich, Gustavo S., Fatima, Javairiah, Sarac, Timur, Cha, Stephen, Kalra, Manju, De Martino, Randall, Bower, Thomas C.·2014·Journal of Vascular Surgery
DOI 10.1016/j.jvs.2014.08.093
Open this paper in CoChat — free account

Abstract

Objective Outcomes of reinterventions for failing mesenteric open reconstructions (ORs) have not been described. Mesenteric reoperative ORs (R-ORs) are challenging because of excessive scar and more advanced mesenteric disease. The purpose of this study was to evaluate outcomes of R-ORs and endovascular revascularization (ER) in patients with stenosis or occlusion of mesenteric grafts. Methods We reviewed 701 patients treated for chronic mesenteric ischemia (CMI) in two academic centers from 1991 to 2013. Clinical data and outcomes of patients treated for failing ORs with R-ORs or ERs were included in the analysis. A 1:2 case-control matching was used to analyze outcomes of R-ORs compared with patients who underwent their first-time ORs for CMI. End points were early and late mortality, morbidity, patency rates, and freedom from symptom recurrence and reintervention. Results There were 47 patients (five men, 42 women; mean age, 58 ± 13 years) with failing ORs who were treated by R-ORs. Clinical presentation was CMI in 38 patients (81%) or acute mesenteric ischemia (AMI) in nine (19%). Reinterventions included R-ORs in 28 patients (19 CMI and nine AMI) and ERs in 19, all for CMI. Early mortality was 22% in patients treated by R-ORs for AMI. There were no early deaths among patients treated for CMI with R-OR or ER. Early morbidity was 78% for R-ORs in patients treated for AMI. Morbidity was significantly higher for R-ORs than for ERs in patients with CMI (63% vs 16%; P < .05). Mean follow-up was 50 ± 60 months. Patient survival at 5 years was 60% ± 8% for the entire cohort. Primary and secondary patency at 1 year were 61% ± 10% and 92% ± 8% for R-ORs (P = .34) and 77% ± 10% and 100% for ERs (P = .41). Freedom from symptom recurrence and reinterventions at 1 year was 88% ± 6% and 87% ± 7% for R-ORs and 83% ± 8% and 71% ± 10% for ERs. Case case-control (1:2) matching showed R-OR was associated with similar early mortality and morbidity and also similar freedom from recurrence and reintervention but with lower primary patency rates at 1 year compared with first time ORs (66% ± 11% and 94% ± 5%; P < .05). Conclusions R-OR or ER interventions for failing mesenteric ORs carry similar mortality, recurrence, and reintervention rates. Early morbidity is lower with ER compared with R-OR. R-ORs are associated with similar morbidity and mortality and lower primary patency compared with first-time OR for CMI.

Integrity signals

Registry

Crossref · 10.1016/j.jvs.2014.08.093

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Kanamori, K. S., Oderich, G. S., Fatima, J., Sarac, T., Cha, S., Kalra, M., De Martino, R., & Bower, T. C.
Affiliations
  • Mayo Clinic (US)
  • Cleveland Clinic (US)
ORCID
Venue
Journal of Vascular Surgery
Publisher
Elsevier BV
Published
2014-12
Volume
60
Issue
6
Pages
1612-1619.e2
ISSN
0741-5214 (ISSN-L)
DOI
10.1016/j.jvs.2014.08.093
OpenAlex
W2136481127
Cited by
17
References
22
Citations by year
2026: 2 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2018: 1 · 2017: 4 · 2015: 2
FWCI
1.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Vascular Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Health Sciences › Medicine › Surgery › Infectious Aortic and Vascular Conditions
Keywords
endovascular revascularization, mesenteric ischemia, chronic mesenteric ischemia, acute mesenteric ischemia, graft occlusion, reintervention, graft patency, postoperative morbidity, mortality, symptom recurrence, endovascular stent graft
MeSH terms
Adult, Aged, Female, Graft Occlusion, Vascular, Humans, Male, Middle Aged, Minnesota, Ohio, Reoperation, Risk Factors, Time Factors, Tomography, X-Ray Computed, Vascular Patency, Treatment Failure, Disease-Free Survival, Plastic Surgery Procedures, Blood Vessel Prosthesis Implantation, Kaplan-Meier Estimate, Endovascular Procedures, Mesenteric Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review